Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome

Importance. Rituximab was not effective in ameliorating the hearing loss in a patient with atypical Cogan’s syndrome. Observations. We report the case of a patient who developed acute bilateral uveitis and sensorineural hearing loss. A diagnosis of atypical Cogan’s syndrome was made. The patient’s h...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel R. Bunker, Leslie Dubin Kerr
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Rheumatology
Online Access:http://dx.doi.org/10.1155/2016/8352893
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563382332424192
author Daniel R. Bunker
Leslie Dubin Kerr
author_facet Daniel R. Bunker
Leslie Dubin Kerr
author_sort Daniel R. Bunker
collection DOAJ
description Importance. Rituximab was not effective in ameliorating the hearing loss in a patient with atypical Cogan’s syndrome. Observations. We report the case of a patient who developed acute bilateral uveitis and sensorineural hearing loss. A diagnosis of atypical Cogan’s syndrome was made. The patient’s hearing loss did not improve despite high dose steroids and azathioprine. Rituximab was administered given a recent report of its efficacy in a patient with refractory disease; however, our patient’s hearing loss did not improve. Conclusion. Hearing loss in Cogan’s syndrome is difficult to treat. Though rituximab was ineffective in our case, earlier administration in the disease course could be effective for future patients.
format Article
id doaj-art-c2ec41baac5042089d3adc992704ac4e
institution Kabale University
issn 2090-6889
2090-6897
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Rheumatology
spelling doaj-art-c2ec41baac5042089d3adc992704ac4e2025-02-03T01:20:26ZengWileyCase Reports in Rheumatology2090-68892090-68972016-01-01201610.1155/2016/83528938352893Rituximab Not Effective for Hearing Loss in Cogan’s SyndromeDaniel R. Bunker0Leslie Dubin Kerr1Department of Medicine, Division of Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USADepartment of Medicine, Division of Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USAImportance. Rituximab was not effective in ameliorating the hearing loss in a patient with atypical Cogan’s syndrome. Observations. We report the case of a patient who developed acute bilateral uveitis and sensorineural hearing loss. A diagnosis of atypical Cogan’s syndrome was made. The patient’s hearing loss did not improve despite high dose steroids and azathioprine. Rituximab was administered given a recent report of its efficacy in a patient with refractory disease; however, our patient’s hearing loss did not improve. Conclusion. Hearing loss in Cogan’s syndrome is difficult to treat. Though rituximab was ineffective in our case, earlier administration in the disease course could be effective for future patients.http://dx.doi.org/10.1155/2016/8352893
spellingShingle Daniel R. Bunker
Leslie Dubin Kerr
Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome
Case Reports in Rheumatology
title Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome
title_full Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome
title_fullStr Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome
title_full_unstemmed Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome
title_short Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome
title_sort rituximab not effective for hearing loss in cogan s syndrome
url http://dx.doi.org/10.1155/2016/8352893
work_keys_str_mv AT danielrbunker rituximabnoteffectiveforhearinglossincoganssyndrome
AT lesliedubinkerr rituximabnoteffectiveforhearinglossincoganssyndrome